Randomized, double blind and dose titration study comparing the efficacy and safety of Lescol (R) (Fluvastatin) vs placebo in treatment of CAPD patients with hyperlipidaemia in Hong Kong
Professor Janus, Edward Denis (Principal investigator)
Dr Li (Co-Investigator)
Dr Tui (Co-Investigator)
Other Funding Scheme
Accelerated atherosclerosis and hyperlipidaemia are common in patients with chronic renal failure treated with continuous ambulatory peritoneal dialysis. This accelerated atherosclerosis is a major factor in their increased morbidity and mortality. This study tests the safety and efficacy of treatment of the hyperlipidaemia.